Albeit the expression level and pattern of PIEZO1 showed significant heterogeneity among different patients, our result showed that the expression of PIEZO1 had no correlation with ESCC tumor stage and progression, suggesting that targeting PIEZO1 with ADC would not bring any additional tumor facilitating effect (Table 2). The gene discussed is PIEZO1; the disease is esophageal squamous cell carcinoma.